| Literature DB >> 23443162 |
Yu-Chang Chen1, His-Lin Chiu, Che-Yi Chao, Wen-Hsin Lin, Louis Kuoping Chao, Guan-Jhong Huang, Yueh-Hsiung Kuo.
Abstract
Three new benzenoids, 3-isopropenyl-2-methoxy-6-methyl-4,5-methylenedioxy- phenol (1), 2-hydroxy-4,4'-dimethoxy-3,3'-dimethyl-5,6,5',6'-bimethylenedioxybiphenyl (2), 4,4'-dihydroxy-3,3'-dimethoxy-2,2'-dimethyl-5,6,5',6'-bimethylenedioxybiphenyl (3), together with two known benzenoids, 2,3,6-trimethoxy-5-methylphenol (4) and 2,3-methylenedioxy- 4-methoxy-5-methylphenol (5), were isolated from Antrodia camphorata. Our results support that compounds 1-5 potently inhibited LPS (lipopolysaccharide)-induced nitric oxide (NO) production in a dose-dependent manner. The IC(50) values of compounds 1, 3 and 5 were 1.8 ± 0.2, 18.8 ± 0.6 and 0.8 ± 0.3 μg/mL, respectively.Entities:
Year: 2013 PMID: 23443162 PMCID: PMC3634465 DOI: 10.3390/ijms14034629
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The chemical structures of compounds 1–5.
1H- and 13C-nuclear magnetic resonance (NMR) data (CDCl3, 500 and 125 MHz, resp.) of Compounds 1–3. Chemical shifts δ in ppm rel. to TMS, J in Hz. For atom numbering, see the Formulae.
| Position | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| δH | δC | δH | δC | δH | δC | |
| 1 | – | 132.0 | – | 129.3 | – | 123.7 |
| 2 | – | 138.5 | – | 135.6 | – | 114.6 |
| 3 | – | 97.1 | – | 116.8 | – | 136.0 |
| 4 | – | 136.0 | – | 135.0 | – | 133.2 |
| 5 | – | 133.0 | – | 136.0 | – | 138.9 |
| 6 | – | 110.0 | – | 133.4 | – | 133.3 |
| 7 | – | 127.2 | – | – | – | – |
| Me-2 | – | – | – | – | 1.82 (s) | 12.7 |
| Me-3 | – | – | 1.97 (s) | 9.4 | – | – |
| Me-6 | 2.27 (s) | 13.3 | – | – | – | – |
| MeO-2 | 3.94 (s) | 60.4 | – | – | – | – |
| MeO-3 | – | – | – | – | 3.88 (s) | 60.1 |
| MeO-4 | – | – | 3.88 (s) | 60.1 | – | – |
| Me-7 | 1.99 (s) | 23.5 | – | – | – | – |
| CH2-7 | 5.24 (br s) | 121.0 | – | – | – | – |
| 5.36 (br s) | ||||||
| 4-OCH2O-5 | 5.93 (s) | 101.7 | – | – | – | – |
| 5-OCH2O-6 | – | – | 5.96 (s) | 101.8 | 5.99 (s) | 101.7 |
| 1′ | – | – | – | 136.1 | – | 123.7 |
| 2′ | – | – | 5.94 (s) | 109.5 | – | 114.6 |
| 3′ | – | – | – | 124.1 | – | 136.0 |
| 4′ | – | – | – | 137.4 | – | 133.2 |
| 5′ | – | – | – | 138.6 | – | 138.9 |
| 6′ | – | – | – | 134.4 | – | 133.3 |
| Me-2′ | – | – | – | – | 1.82 (s) | 12.7 |
| Me-3′ | – | – | 2.03 (s) | 15.8 | – | – |
| MeO-3′ | – | – | – | – | 3.88 (s) | 60.1 |
| MeO-4′ | – | – | 3.87 (s) | 59.7 | – | – |
| 5′-OCH2O-6′ | – | – | 5.98 (s) | 101.7 | 5.99 (s) | 101.7 |
| OH | 4.64 (s) | – | – | – | 4.56 (s) | – |
exchangeable;
exchangeable.
Figure 2Nuclear Overhauser Effect Spectroscopy (NOESY) contacts (a) and key Heteronuclear Multiple Bond Correlation (HMBC) connectivities (b) of compound 1.
Figure 3NOESY contacts (a) and key HMBC connectivities (b) of compound 2.
Figure 4NOESY contacts (a) and key HMBC connectivities (b) of compound 3.
Cell viability and effect of compounds 1–5 on LPS-induced NO production in macrophages a.
| Compound | Dose (μg/mL) | Cell viability (% of control) | NO level (μM) | IC50 (μg/mL) |
|---|---|---|---|---|
| control | (−) | 96.4 ± 4.3 | 2.5 ± 0.2 | |
| LPS | (+) | 97.0 ± 0.8 | 25.3 ± 3.0 | |
|
| ||||
| 0.312 | 92.0 ± 3.3 | 14.5 ± 2.2 | 1.8 ± 0.2 | |
| 0.625 | 91.0 ± 3.7 | 14.1 ± 1.5 | ||
| 1.25 | 90.4 ± 2.4 | 13.0 ± 1.5 | ||
| 2.5 | 87.3 ± 2.3 | 12.0 ± 1.7 | ||
| 5 | 65.5 ± 1.7 | (−) | ||
|
| ||||
| 0.312 | 98.0 ± 1.5 | 16.4 ± 2.4 | ||
| 0.625 | 96.6 ± 7.6 | 16.1 ± 1.3 | ||
| 1.25 | 96.6 ± 2.2 | 15.7 ± 2.0 | ||
| 2.5 | 92.7 ± 1.3 | 15.5 ± 1.9 | ||
| 5 | 71.4 ± 2.2 | (−) | ||
|
| ||||
| 3.12 | 95.1 ± 2.9 | 13.7 ± 0.1 | 18.8 ± 0.6 | |
| 6.25 | 93.1 ± 2.7 | 13.4 ± 0.4 | ||
| 12.5 | 93.0 ± 2.6 | 13.2 ± 0.1 | ||
| 25 | 91.0 ± 7.7 | 12.1 ± 0.6 | ||
| 50 | 64.8 ± 2.2 | (−) | ||
|
| ||||
| 0.312 | 97.0 ± 1.1 | 20.6 ± 1.2 | ||
| 0.625 | 96.2 ± 2.2 | 19.4 ± 2.0 | ||
| 1.25 | 95.0 ± 2.1 | 18.3 ± 0.3 | ||
| 2.5 | 94.6 ± 1.6 | 13.6 ± 0.6 | ||
| 5 | 69.3 ± 2.1 | (−) | ||
|
| ||||
| 0.312 | 93.8 ± 2.9 | 15.2 ± 1.4 | 0.8 ± 0.3 | |
| 0.625 | 88.5 ± 1.5 | 12.8 ± 1.9 | ||
| 1.25 | 85.0 ± 2.9 | 12.1 ± 1.6 | ||
| 2.5 | 83.8 ± 1.9 | 10.4 ± 1.3 | ||
| 5 | 82.4 ± 2.7 | 10.0 ± 2.2 | ||
|
| ||||
| Indomethacin | 25 | 96.2 ± 1.1 | 19.2 ± 0.6 | |
| 50 | 94.8 ± 1.3 | 14.3 ± 0.8 | ||
The data were presented as the mean ± SD for three different experiments performed in triplicate.
Compared with sample of the control group.
p < 0.05,
p < 0.01 and
p < 0.001 were compared with the LPS-alone group.